RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Alta Life Sciences
A

Alta Life Sciences portfolio

Alta Life Sciences has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months. Its most recent investment on record is Ona Therapeutics's $86.6M Series B+ round in June 2026, alongside Mérieux Equity Partners, Columbus Venture Partners, Ysios Capital and 6 others. That company is in Health and bio. It has co-invested with Bpifrance, Asabys Partners and Ysios Capital, most often Bpifrance (2 rounds).

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 1.
Capital in their rounds: $120.52M.
Latest deal: Ona Therapeutics · Jun 4, 2026.

What Alta Life Sciences invests in

How Alta Life Sciences invests

StageDealsCapital in rounds
Series A 1 50%$33.92M
Series B+ 1 50%$86.6M
YearDealsCapital in rounds
2020 1 50%$33.92M
2026 1 50%$86.6M

Share is of the 2 rounds on Recent Funding that name Alta Life Sciences. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Alta Life Sciences portfolio companies

CompanyRound with Alta Life SciencesTotal raisedLatest raise
OOna Therapeutics
Health and bio
Series B+ · $86.6M$207.12MOct 5, 2026
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Alta Life Sciences, which is a subset of its real portfolio. API: /api/v1/investors/alta-life-sciences (get a free API key). More: the most active VC firms and new venture capital funds.